// Who He Is
Tony Verzura is a representative of United Cannabis who brought a pharmaceutical perspective to Hash Church. He introduced the P1-P5 sublingual formulation system — a standardised approach to cannabis medicine that pairs specific cannabinoid ratios with electronic health record (EHR) patient tracking. His appearances bridged the gap between artisanal hash making and clinical cannabis medicine.
// On Hash Church
Tony first appeared in Episode 3 and returned across several early episodes, each time deepening the medical dimension of Hash Church's discussions. While much of the show focused on extraction technique and trichome science, Tony consistently steered conversations toward patient outcomes — what specific cannabinoid ratios do for specific conditions, and why standardisation matters for medical legitimacy. His presentations on the P1-P5 system gave the panel concrete examples of how cannabis can be formulated with the same precision expected of pharmaceutical products.
// Key Contributions
Tony's most significant contribution was the P1-P5 system: five sublingual formulations targeting different therapeutic profiles. P1 (THCA-dominant) for non-psychoactive cannabinoid support. P2 (CBD ratios) for epilepsy and anxiety. P3 (THC:CBD balanced) for pain. P4 (CBD:CBN) for sleep disorders. P5 (raw acidic cannabinoids) for those exploring undecarboxylated medicine. The EHR tracking component was presented as revolutionary — building the clinical evidence base that cannabis medicine has historically lacked. He shared compelling case studies, including a child with autism using P2/P4 drops at just 6-8mg per day, costing $1.30 daily — a stark contrast to the cost of conventional pharmaceutical alternatives.